Try our Advanced Search for more refined results
Stamoulis & Weinblatt
-
Misc | Filed: April 29, 2024 | Entered: April 29, 2024 Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc., et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Deficiency Notice - No 7.1 Statement Filed
DEFICIENCY NOTICE issued by the Court to Defendant Gerbera Therapeutics, Inc.: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. Associated Cases: 1:23-cv-00401-RGA, 1:20-md-02930-RGA, 1:22-cv-01395-RGA(nms)
-
Misc | Filed: April 29, 2024 | Entered: April 29, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Deficiency Notice - No 7.1 Statement Filed
DEFICIENCY NOTICE issued by the Court to Defendant Gerbera Therapeutics, Inc.: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. Associated Cases: 1:23-cv-00401-RGA, 1:20-md-02930-RGA, 1:22-cv-01395-RGA(nms)
-
Order | Filed: April 29, 2024 | Entered: April 29, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Oral Order
ORAL ORDER: The redacted filings (D.I. 1340 in 20md2930-RGA; D.I. 69 in 23cv410-RGA) are REJECTED because parts of them are redacted in entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document, or parts of it, that contains publicly available materials is prima facie evidence of bad faith. A revised redacted filing is DUE within five business days. Ordered by Judge Richard G. Andrews on 4/29/2024. Associated Cases: 1:20-md-02930-RGA, 1:23-cv-00401-RGA(nms)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login